A detailed history of Horizon Wealth Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Horizon Wealth Management, LLC holds 3,467 shares of ABBV stock, worth $590,603. This represents 0.14% of its overall portfolio holdings.

Number of Shares
3,467
Previous 3,454 0.38%
Holding current value
$590,603
Previous $592,000 15.54%
% of portfolio
0.14%
Previous 0.14%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

BUY
$163.84 - $199.33 $2,129 - $2,591
13 Added 0.38%
3,467 $684,000
Q2 2024

Jul 19, 2024

SELL
$154.79 - $180.76 $8,358 - $9,761
-54 Reduced 1.54%
3,454 $592,000
Q1 2024

Apr 18, 2024

BUY
$159.82 - $182.1 $17,740 - $20,213
111 Added 3.27%
3,508 $638,000
Q4 2023

Jan 22, 2024

SELL
$137.6 - $154.97 $2,614 - $2,944
-19 Reduced 0.56%
3,397 $526,000
Q3 2023

Oct 24, 2023

BUY
$133.59 - $154.65 $2,137 - $2,474
16 Added 0.47%
3,416 $509,000
Q2 2023

Jul 31, 2023

BUY
$132.51 - $164.9 $2,120 - $2,638
16 Added 0.47%
3,400 $458,000
Q1 2023

May 11, 2023

BUY
$144.61 - $166.54 $2,313 - $2,664
16 Added 0.48%
3,384 $539,000
Q4 2022

Feb 09, 2023

SELL
$138.31 - $165.87 $19,086 - $22,890
-138 Reduced 3.94%
3,368 $544,000
Q3 2022

Nov 18, 2022

SELL
$134.21 - $153.93 $207,220 - $237,667
-1,544 Reduced 30.57%
3,506 $471,000
Q2 2022

Aug 02, 2022

BUY
$137.62 - $174.96 $110,646 - $140,667
804 Added 18.94%
5,050 $773,000
Q1 2022

May 12, 2022

BUY
$131.98 - $163.75 $1,715 - $2,128
13 Added 0.31%
4,246 $688,000
Q4 2021

Feb 14, 2022

BUY
$107.43 - $135.93 $454,751 - $575,391
4,233 New
4,233 $573,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $301B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Horizon Wealth Management, LLC Portfolio

Follow Horizon Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Horizon Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Horizon Wealth Management, LLC with notifications on news.